Abstract

Abstract:

Improved process for the preparation of 4-((6,7-dimethoxyquinolin-4-yl)oxy)aniline of formula-1, which is represented by the following structural formula:

which is key intermediate for the preparation of Cabozantinib, which is chemically known as N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4­fluorophenyl)cyclopropane-1,1-dicarboxamide or its salts such as malate, fumarate or etc.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS